Menu

  • Therapies & Procedures
  • Conditions
  • Media Kit
  • MRI Information
  • Reimbursement



    • Help your patients move with confidence

    Medtronic deep brain stimulation (DBS) therapy is safe and effective for the management of chronic, oral and/or injectable medication refractory

    • Primary generalized, segmental†, and cervical dystonia in adults
    • Primary generalized dystonia in pediatric patients 12 years or older

    DBS improves motor, disability, and severity scores over time1

    Adult (Generalized or segmental†)

    >60%

    average improvement in Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) motor score1
    (generalized n=130
    segmental n=94)

    Adult (Cervical)

    58%

    improvement in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) severity score on average‡,1
    (n=245)

    Pediatrics (Generalized)

    71%

    average improvement in BFMDRS motor score1
    (n=143)

    Reduces pain

    51%

    reduction in pain at 6 months for adult patients with cervical dystonia
    (n=58)2

    Pain reduction sustained up to

    10 years

    experienced by adult patients with generalized or segmental dystonia†
    (n=28)1, 3-5

    See more data
    Download brochure (open in new window)

    Learn more about the Percept™ family with BrainSense™ technology§

    The first sensing-enabled DBS system offering insights into a patient’s condition inside and outside of the clinic throughout the patient journey.

    Percept™ RC neurostimulator (open in new window)
    Percept™ PC neurostimulator (open in new window)

    Is your patient with dystonia a candidate for DBS therapy?

    DBS for dystonia may be appropriate if your patient has chronic primary dystonia, including:

    • Generalized, segmental†, or cervical dystonia (torticollis) in adult patients
    • Generalized dystonia in patients 12 years of age or above
    • Cannot manage symptoms with oral and/or injectable medications or tolerate the side effects

    Risks


    DBS therapy may help manage some of the symptoms of dystonia, including involuntary movements, but it is not a cure. Potential risks related to the device, therapy, or surgery can include implant site pain, tingling sensations, ineffective stimulation, and implant site infection.

    Possible side effects with DBS therapy for dystonia might include:

    • Status dystonicus
    • Risk of depression, suicidal ideations, and suicide
    • Rebound effect: an abrupt cessation of stimulation may cause a return of disease symptoms and in some cases with a greater intensity than prior to implant
    • Pediatric patients may have increased risk of infections and device-related complications.

    Explore Percept™ products.

    Discover the Percept™ family of DBS products with BrainSense™ technology. 

    View product family

    DBS Academy

    Access on-demand DBS resources, procedural videos, webinars, and more at DBS Academy.

    Visit DBS Academy (open in new window)

    Contact Medtronic.

    U.S. clinician services: 

    800-328-0810